# NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL

> **NCT06276101** · PHASE1 · UNKNOWN · sponsor: **Newish Technology (Beijing) Co., Ltd.** · enrollment: 9 (estimated)

## Conditions studied

- High-grade Squamous Intraepithelial Lesion (HSIL)

## Interventions

- **BIOLOGICAL:** NWRD08 administered by electroporation

## Key facts

- **NCT ID:** NCT06276101
- **Lead sponsor:** Newish Technology (Beijing) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-25
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06276101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06276101, "NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06276101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*